Life Science Insights360
Life Science Insights 360 Podcasts
Welcome to Life Science Insights360, your go-to source for deep conversations with the innovators shaping the future of healthcare, biotech, and life sciences. Hosted by Senthil Karunanith, each episode dives into cutting-edge topics—from translational omics and therapeutic breakthroughs to strategic data insights, quality management, and real-world challenges in pharma, medtech, and diagnostics .Expect dynamic interviews with industry leaders—CEOs, scientists, strategists—who share real-world case studies and forward-thinking visions.
Be sure to visit the podcast's website and support the creator: podcasters.spotify.com
Author
Life Science Insights360
Category
Podcast website
Latest episode
Nov 3, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
E36 - Immunotherapies for Rare cancers and Future of Oncology |Paul Romness, CEO of OS Therapies 03.11.2026 27:33
In this episode,we welcome Paul Romness, CEO of OS Therapies, a clinical-stage biotechnology company developing innovative immunotherapies and targeted drug conjugates for osteosarcoma, breast cancer, and other solid tumors. With a distinguished background in biotechnology leadership and public policy, including his previous role as Vice President of Government Affairs & Public Policy at Boehr...
E35 - Building the Future of Cell Therapy |Dr. Ron Cohen CEO of Oryon Cell Therapies 17.09.2026 59:34
We are honored to welcome Dr. Ron Cohen, CEO of Oryon Cell Therapies and a distinguished leader in the biotechnology industry. With more than three decades of experience building innovative biotech companies, raising significant capital, and advancing therapies for patients, Dr. Cohen has made a lasting impact on the life sciences community. At Oryon Cell Therapies, he is leading the development o...
E34 - The Science of One Health | Dr. Alex Shneider, CEO CureLab Oncology and CureLab Veterinary 14.09.2026 52:58
Dr. Shneider is pioneering innovative approaches to cancer treatment through Elenagen, a novel biological therapeutic being investigated for difficult-to-treat cancers. His unique approach connects human and veterinary oncology, advancing the One Health vision while challenging conventional approaches to biotechnology development. In this conversation, we explore Dr. Shneider’s journey in biotechn...
E33 - Next Generation of CDMO Innovation | Elizabeth Hickman, CEO of AustinPx 03.09.2026 29:27
With more than two decades of experience across organizations including West Pharmaceutical Services and Catalent, Elizabeth brings deep expertise in transforming scientific innovation into scalable solutions that help biopharma companies accelerate drug development and bring innovative therapies to patients. Our conversation explores the evolution of the CDMO industry, AustinPx’s innovative Kinet...
E32 - Future of Digital Transformation in Life Sciences | Ivanna Rosendal, VPBusiness Digitalization 11.08.2026 25:04
In this episode of Life Science Insights 360, I'm delighted to welcome Ivanna Rosendal, Vice President of Business Digitalization, a global leader driving digital transformation across clinical development, pharmacovigilance, commercial, and medical organizations. Beyond her executive leadership role, Ivanna is also an author, podcast host, and stand-up comedian, bringing a unique perspective...
E31 - Next Frontier in Skin Cancer Care | Dr. Faisal Mehmud, Chief Medical Officer of Medicus Pharma 11.08.2026 30:55
In this episode of the Life Science Insights Podcast , I'm delighted to welcome Dr. Faisal Mehmud, Chief Medical Officer of Medicus Pharma , a clinical-stage biotechnology company focused on developing innovative therapies for oncology and other high unmet medical needs. With an exceptional career spanning global pharmaceutical leaders including Sanofi, Novartis, Bristol Myers Squibb, Pfizer,...
E30 - The Science Behind Programmable Stem Cells |Dr. John Craighead, CEO of Syntax Bio 08.08.2026 42:25
In this episode of the Life Science Insights Podcast, I'm delighted to welcome Dr. John Craighead, CEO of Syntax Bio, a synthetic biology company advancing the next generation of programmable stem cell therapies. With more than 20 years of leadership experience across biotechnology, corporate strategy, and life sciences, Dr. Craighead has held executive leadership roles at organizations includ...
E29 - The Future of Clinical Research Sites | Jimmy Bechtel (CSSO, SCRS) | Life Science Insights 09.07.2026 33:28
In this episode of the Life Science Insights Podcast, we sit down with Jimmy Bechtel, Chief Strategy & Site Solutions Officer (CSSO) at the Society for Clinical Research Sites (SCRS), to explore the evolving landscape of clinical research and the critical role research sites play in advancing innovation, improving patient outcomes, and driving more efficient clinical trials. Jimmy shares his p...
E28 - Bridging Scientific Breakthroughs & Commercial Success | Mark Van Zee, Saku Biosciences 09.07.2026 31:53
In this episode of the Life Science Insights Podcast, we sit down with Mark Van Zee, Founder and CEO of Saku Biosciences, to explore the future of scalable biology and how innovations in cell line development are transforming modern biomanufacturing. Mark shares his journey from bioengineering research to entrepreneurship and explains why the greatest challenge facing biotechnology today is not sc...
E27 - Accelerating Drug Development with AI | Dr. Raviv Pryluk, CEO & Co-Founder of PhaseV 09.07.2026 31:11
In this episode of the Life Science Insights Podcast, we sit down with Dr. Raviv Pryluk, CEO and Co-Founder of PhaseV, to explore how artificial intelligence and causal machine learning are transforming clinical development. Dr. Pryluk explains how AI-driven trial optimization is making clinical trials faster, smarter, and more efficient—while reducing costs, minimizing risk, and improving the pro...
E26 - How Peptides Are Evolving Beyond Traditional Drugs | Karsten Eastman, CEO & Co-founder 09.07.2026 23:24
In this episode of the Life Science Insights Podcast, we sit down with Karsten Eastman, CEO and Co-founder of Sethera Therapeutics, to explore how innovative enzyme-based technologies are transforming drug discovery. Karsten shares the inspiration behind founding Sethera, the scientific challenges the company is addressing, and how its unique platform is enabling the discovery of next-generation p...
E25 - Reimagining Medtech Innovation | Holly Coter T| Co-Founder, indieMedTech 17.06.2026 36:07
In this episode of the Life Science Insights Podcast, we explore the future of MedTech collaboration, innovation, and community-driven growth with , Co-Founder of and White Lamb Medtech Consulting. In a conversation about her journey building platforms that connect MedTech professionals, strengthen industry partnerships, and support meaningful collaboration across the healthcare ecosystem. With ov...
E24 - Transforming Scientific Documents with AI | Levi S. Lian | CEO & Founder, Raycaster 06.04.2026 59:57
In this episode, we sit down with Levi S. Lian, CEO and Founder of Raycaster, to explore the critical evolution of document intelligence within the enterprise landscape. Drawing from a background that spans Stanford, Harvard Business School, and a deep-rooted family history in medicine, Levi shares his unique perspective on building AI-driven infrastructure that tackles one of the most persistent...
E23 - Building a Therapeutics Platform from the Ground Up | Dr. Stanley Lewis, CEO of A28 Therapeutics 23.03.2026 28:26
In this episode, we are joined by Dr. Stanley T. Lewis, MD, MPH, Founder and CEO of A28 Therapeutics, to trace his profound transition from physician-scientist to biotech entrepreneur. With a career rooted in translational medicine and clinical development, Dr. Lewis provides an expert perspective on the arduous journey of moving innovation from the laboratory bench to the patient’s bedside. We di...
E22 - Advancing the Future of Therapeutics | Ganesh Iyer, CEO & Founder, Opprtna Therapeutics 02.03.2026 48:06
In this episode, we sit down with Ganesh Iyer, CEO and Founder of Opprtna Therapeutics and Drug Discovery Partners, to explore the high-stakes world of deep science entrepreneurship. Ganesh shares the personal and professional motivations that led him to tackle some of medicine's most formidable challenges—neurodegeneration and cancer. We delve into the founding vision of Opprtna and its pursu...
E21 - Innovation Infrastructure and Future of Synthetic Biology | Jodi Barrientos CEO, Ribbon Bio 23.02.2026 30:13
In this episode, we sit down with Jodi Barrientos, CEO of Ribbon Bio, to explore how innovation infrastructure is shaping the future of synthetic biology—and why scalable DNA manufacturing is critical to unlocking the next generation of biological breakthroughs. Jodi shares her journey from bench scientist to biotech entrepreneur, reflecting on the pivotal moments that inspired her to build a deep...
E20 - Re-inventing Precision Medicine with AI | Jolly Nanda, Founder and CEO, Altheia, Inc 09.02.2026 37:21
In this episode, we sit down with Jolly Nanda, Founder and CEO of Altheia, Inc., to explore how artificial intelligence is transforming precision medicine from a reactive model into one that is predictive, personalized, and proactive. Jolly shares her entrepreneurial journey and the inspiration behind founding Altheia, highlighting the gaps she observed in traditional precision medicine approaches...
E19 - Future of Innovation and Ecosystem | James Zanewicz CEO, Connect 19.01.2026 32:19
In this episode, we explore how San Diego is evolving as a global innovation hub—and what it will take to shape its next chapter at the convergence of AI, DefenseTech, and Life Sciences. Long recognized for its strengths in biotech and research institutions, San Diego is now entering a new phase defined by cross-sector collaboration and technological convergence. We examine what differentiates the...
E18 - Re-Imagining Clinical Development Strategy|Suzanne Vyvoda Founder,CEO of Concordia BioStrategies 05.01.2026 51:37
In this episode, we sit down with Suzanne Vyvoda, Founder and CEO of Concordia BioStrategies, to explore how strategic leadership, operational rigor, and collaborative execution form the foundation of successful biotech companies. Suzanne shares her journey to becoming a founder, CEO, and trusted strategic partner to emerging biotech organizations. She reflects on the philosophy behind Concordia B...
E17 - Driving Diversity in Clinical Research | Golda Naana Boakye CEO Naantu 29.12.2025 51:11
Join us for a powerful and timely episode featuring Golda Naana Boakye, CEO of Naantu, as we examine the urgent need to advance diversity, equity, and inclusion in clinical research. In this compelling conversation, Golda shares why representative clinical trials are not only a matter of social responsibility, but a scientific and clinical imperative essential to improving outcomes for all patient...
E16 - How BioPharma Leaders Drive Growth | Ramani Varanasi, Founder and CEO, ReVive Advisors 15.12.2025 45:05
Join us for a strategic and deeply insightful episode featuring Ramani Varanasi, Founder and CEO of ReVive Advisors, as we explore the leadership mindset, capital strategy, and decision-making discipline required to build and scale successful biopharma companies. Drawing from his journey from bench scientist to executive leader, entrepreneur, and trusted board advisor, Ramani shares practical less...
E15 - Exploring Scientific Innovation | Dr. Dirk Heckel, CTO at Siemens Healthineers 01.12.2025 48:23
In this episode of Life Science 360 , we sit down with Dr. Dirk Heckel, Chief Technology Officer of Siemens Healthineers, to explore how technology, informatics, and data-driven innovation are redefining modern diagnostics and transforming clinical laboratories worldwide. Dr. Heckel shares his unique career journey—rooted in both science and technology—and how this dual foundation has shaped his l...
E14 - Lab Bench to Boardroom: Leading Science-Driven Innovation | Ashley Zehnder, CEO, Fauna Bio 17.11.2025 30:38
Join us for an inspiring episode of Lab Bench to Boardroom: Leading Science-Driven Innovation featuring Ashley Zehnder, CEO of Fauna Bio, as we explore the intersection of bold scientific thinking, biotech leadership, and nature-inspired therapeutics. In this conversation, Ashley shares how Fauna Bio is redefining drug discovery by leveraging multi-omics insights from hibernating species to tackle...
E13 - Pharma Frameworks: From Strategy to Safety | Alan White, CEO of Arriello 03.11.2025 57:20
Join us for an in-depth and thought-provoking episode featuring Alan White, CEO and Co-founder of Arriello, as we explore the evolving world of global regulatory affairs, pharmacovigilance, quality, and compliance—and the powerful intersection of technology and human expertise that is redefining life sciences. In this conversation, Alan shares his unconventional journey from a commercial career sp...
E12 - Make Clinical, Regulatory & Medical Research 10X Faster | NyquistAI CEO on AI in Life Sciences 20.10.2025 42:50
Join us for a compelling episode featuring the Cofounder and CEO of NyquistAI, a pioneering leader shaping the future of clinical, regulatory, and medical research through artificial intelligence. With a background spanning BCG, Novartis, Google Accelerator, and Stanford, he brings a rare blend of strategic, scientific, and technical expertise to the conversation—offering an inside look at how Nyq...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.